Japan's Daiichi Sankyo to commercialise mRNA vaccine against COVID-19 in 2022
Vaccines | News | 0 Comment | 03 Jun, 2022
Daiichi Sankyo has announced the current progress of development of DS-5670, an mRNA vaccine, being evaluated in Japan a...Read more
Moderna to become marketing authorization holder in Japan for Spikevax COVID-19 Vaccine
Vaccines | News | 0 Comment | 02 Jun, 2022
Moderna and Takeda have announced to transfer the marketing authorization in Japan for Moderna’s COVID-1...Read more
Korea, Ethiopia establish collaborating centre for joint vaccine research
Vaccines | News | 0 Comment | 25 May, 2022
South Korea-based International Vaccine Institute (IVI) and Armauer Hansen Research Institute (AHRI), established by the...Read more
New Zealand announces funding worth $40.7 M for development of novel mRNA vaccines, therapies
Vaccines | News | 0 Comment | 24 May, 2022
The University of Auckland in New Zealand has received budget funding of $40.7 million for development of novel mRNA vac...Read more
WHO validates China's Convidecia as 11th vaccine for COVID-19
Vaccines | News | 0 Comment | 20 May, 2022
The World Health Organization (WHO) has issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by ...Read more
Korea expands collaboration in vaccine development, delivery & training
Vaccines | News | 0 Comment | 17 May, 2022
The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea (ROK),...Read more
SK bioscience acquires approval for typhoid conjugate vaccine
Vaccines | News | 0 Comment | 17 May, 2022
South Korea-based SK Bioscience has secured another approval for in-house vaccine. SK Bioscience obtained an export lic...Read more
India-Australia collaboration to develop ‘variant-proof’ COVID-19 vaccine
Vaccines | News | 0 Comment | 10 May, 2022
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is providing funding of up to $19.3 million to suppo...Read more
China approves phase 2 trial of recombinant protein COVID-19 vaccine, ReCOV
Vaccines | News | 0 Comment | 05 May, 2022
Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...Read more
Zhifei Lvzhu Biopharmaceutical to commercialise whooping cough vaccine in China
Vaccines | News | 0 Comment | 03 May, 2022
Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...Read more
SK bioscience reaches final stage of developing Korea´s first COVID-19 vaccine
Vaccines | News | 0 Comment | 02 May, 2022
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...Read more
Korean firm GC Biopharma explores use of lipid nanoparticle delivery system in mRNA vaccines
Vaccines | News | 0 Comment | 28 Apr, 2022
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...Read more
Sanofi gears to leverage Evolutive Vaccine Facility (EVF) in Asia by 2025
Vaccines | News | 0 Comment | 20 Apr, 2022
On 20 April 2022, Sanofi launched Evolutive Vaccine Facility (EVF) in Singapore. A first-of-its-kind, the...Read more
Japan approves Novavax's COVID-19 vaccine for primary and booster immunisation
Vaccines | News | 0 Comment | 19 Apr, 2022
Takeda Pharma has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (M...Read more
Korea promotes vaccine development & delivery, bio-manufacturing training for LMICs
Vaccines | News | 0 Comment | 08 Apr, 2022
The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed ...Read more
Thailand gives Emergency Use Authorisation for Novavax' COVID-19 vaccine
Vaccines | News | 1 Comment | 08 Apr, 2022
US-based Novavax, Inc. and Serum Institute of India have announced that the Thailand Food and Drug Administration (Thai ...Read more
CEPI partners with Japan’s NEC Group for AI-designed betacoronavirus vaccine
Vaccines | News | 0 Comment | 08 Apr, 2022
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...Read more
Chinese firms strengthen focus on development and commercialisation of mRNA vaccines
Vaccines | News | 0 Comment | 07 Apr, 2022
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...Read more